spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Owlstone Medicals ReCIVA Named Invention of the Year in Top 50 Digital Health Awards

Owlstone Medical

Awards recognize exceptional progress in bringing technological advancements to healthcare

Cambridge, UK, December 6, 2016: Owlstone Medical, a diagnostics company developing a breathalyzer for disease, announced today that its ReCIVA breath sampling and analysis technology has been named Invention of the Year in the 2017 Top 50 in Digital Health Awards.

Each year ahead of the JP Morgan Health Conference in San Francisco, fifty of the leading entrepreneurs, investors, technologists, reporters, and providers dedicated to bringing technological advancements to healthcare are recognized at the Top 50 in Digital Health Dinner hosted by Rock Health, Fenwick & West, Goldman Sachs, and Square 1 Bank. Within the Top 50, a number of individuals and organizations are awarded through public nominations and votes from the digital health community for making exceptional progress in driving resources, attention, and innovation toward a massively better healthcare system.

Owlstone Medical uses the Respiration Collector for In Vitro Analysis (ReCIVA), in combination with the Field Asymmetric Ion Mobility Spectrometer (FAIMS) sensor platform, to accurately and selectively detect targeted biomarkers of disease in breath (and other bodily fluids).

Billy Boyle, co-founder and CEO at Owlstone Medical, said: “We are delighted that ReCIVA has been named Invention in the 2017 Top 50 Digital Health Awards. Our vision is to save 100,000 lives and $1.5B in health care costs by 2020 with a breath sampling and analysis technology that can diagnose cancer and other diseases earlier than existing tests. This allows for more effective treatment and ultimately, better patient survival rates and reduced treatment costs.”

To find out more about Owlstone Medical visit: www.owlstonemedical.com; for more information on 2017 Top 50 in Digital Health visit www.rockhealth.com/announcing-the-winners-of-the-2017-top-50-in-digital-health/
phone +44 (0)1223 428200
web www.owlstonenanotech.com
email Owlstone Ltd, 127 Cambridge Science Park, Milton Road, Cambridge, CB4 0GD, UK
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Saudia Cargo launches state-of-the-art pharmaceutical cold storage facility at KAIA

MAY 2018 – Saudia Cargo has recently inaugurated one of the Region’s newest and most modern cold storage facilities of pharmaceuticals and medicines at King Abdulaziz International Airport (KAIA) to meet the surged demand on highly-sensitive and temperature-controlled shipments.
More info >>


White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>

Industry Events

BioPharm America 2018

5-6 September 2018, Hynes Convention Center

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement